KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Capital Expenditures (2016 - 2022)

TherapeuticsMD filings provide 12 years of Capital Expenditures readings, the most recent being -$21000.0 for Q2 2022.

  • On a quarterly basis, Capital Expenditures fell 151.22% to -$21000.0 in Q2 2022 year-over-year; TTM through Sep 2022 was $21000.0, a 89.6% decrease, with the full-year FY2021 number at $34000.0, down 83.57% from a year prior.
  • Capital Expenditures hit -$21000.0 in Q2 2022 for TherapeuticsMD, down from $42000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $996909.0 in Q3 2019 to a low of -$70000.0 in Q3 2021.
  • Median Capital Expenditures over the past 5 years was $41000.0 (2021), compared with a mean of $172296.5.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 4745.24% in 2019 and later crashed 638.46% in 2021.
  • TherapeuticsMD's Capital Expenditures stood at $150745.0 in 2018, then surged by 139.2% to $360587.0 in 2019, then plummeted by 53.41% to $168000.0 in 2020, then tumbled by 141.67% to -$70000.0 in 2021, then skyrocketed by 70.0% to -$21000.0 in 2022.
  • The last three reported values for Capital Expenditures were -$21000.0 (Q2 2022), $42000.0 (Q1 2022), and -$70000.0 (Q3 2021) per Business Quant data.